Navigation Links
Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
Date:11/1/2007

SAN DIEGO, Nov. 1 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it has entered into an exclusive licensing agreement for the development and commercialization of indiplon in Japan with Dainippon Sumitomo Pharma Co, Ltd. (DSP). Neurocrine has submitted its New Drug Application (NDA) for indiplon in the US for the treatment of insomnia. The NDA is currently under review by the FDA with a PUDFA action date of December 12, 2007.

Under the terms of the agreement, Neurocrine will receive an initial payment of $20 million and an additional $10 million payment upon FDA approval of indiplon. Neurocrine is eligible to receive additional milestone payments associated with the successful development and commercialization of the indiplon immediate release formulation in Japan. Upon commercialization of indiplon, Neurocrine will receive royalties from DSP based on sales in Japan. DSP also has a right to develop and commercialize the modified release formulation of indiplon in Japan which would result in additional milestone payments and royalties to Neurocrine.

"We are excited to have a leading multi-national pharmaceutical company in Japan with one of the highest and most aggressive sales records in the Japanese market as our commercialization partner for indiplon. Importantly, DSP has a proven track record, which we believe will optimize indiplon's full potential in the growing Japanese insomnia market," said Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences, "the economics of this agreement, given the significant milestones and substantial royalty rate, confirm the value of indiplon."

In 2006, the sedative hypnotic market in Japan was valued
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... innovation and sustainability, the Consulate General of Switzerland in ... solar boat, Switzerland’s MS Tûranor PlanetSolar , to ... part of its DeepWater Expedition 2013 tour with scientists ... led by Capitain Gérard d’Aboville, runs exclusively on energy ...
(Date:6/18/2013)... 2013 Demanding industrial and environmental conditions ... synthetic Sapphire and Glass Ball Lenses, now available in ... Jewel Company , of Philadelphia , PA. , Optical ... the light beams without the need for direct physical ... durability (9 mohs) make it the ideal choice for ...
(Date:6/18/2013)... 2013 Nasseo, Inc. today announces that ... out of hundreds of applicants by the Arizona ... Innovation Challenge . The Arizona Innovation Challenge (AIC) awards ... commercialization challenge, granting a financial award to what it ... Nasseo’s state of the art dental and orthopedic implant ...
(Date:6/18/2013)... 2013  regulated information — Global biopharmaceutical company UCB, ... announced the launch of a new Pledge campaign for ... The Pledge empowers the millions of Americans ... a personal commitment to demand more: greater understanding of ... and additional partial-onset seizure control.  More information is available ...
Breaking Biology Technology:Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6
... June 20, 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Company will present data for its two first-in-class ... acetate) injection, and its investigational diabetes drug candidates ... once monthly at the 71st Scientific Sessions of ...
... YORK, June 20, 2011 Clenergen Corporation (OTCQB: ... offers strategic clean energy generation and supply of biomass ... supplies of electricity. They have assembled an experienced managerial, ... levels of existing combustion steam biomass power plants along ...
... renovation of half the space in a key office ... earned the company Leadership in Energy and Environmental Design ... (USGBC). LEED certification is the USGBC,s rating and recognition ... energy efficient, and highest performing buildings. The designation is ...
Cached Biology Technology:Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 2Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 3Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 4Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 5Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 6Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 7Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 8CLENERGEN - One of India's Largest Biomass Power Generating Companies and a Global Specialist in the Cultivation and the Production of Sustainable Biomass Feedstock - is Available for Meetings in New York From June 20th Until June 30th 2CLENERGEN - One of India's Largest Biomass Power Generating Companies and a Global Specialist in the Cultivation and the Production of Sustainable Biomass Feedstock - is Available for Meetings in New York From June 20th Until June 30th 3Roche Building Awarded LEED® Gold Certification 2Roche Building Awarded LEED® Gold Certification 3
(Date:6/19/2013)... YORK , June 19, 2013  New York ... by the United States Patent and Trademark Office for ... systems that reflect whether guards have been injured, attacked ... an extensive portfolio under the Intellectual Properties Agreements of ... Lisa Pamintuan , President of New York ...
(Date:6/19/2013)... Medicines Agency (EMA) approved the modified adeno-associated virus ... for clinical use in the Western world. uniQure, ... for the treatment of a rare inherited metabolic ... approximately one or two out of one million ... the pancreas. Afflicted individuals carry a defect in ...
(Date:6/18/2013)... University of Calgary,s Faculty of Medicine have discovered a ... harmful bacteria. Platelets, a component of blood typically associated ... bacteria, and upon detection, seal it off from the ... in Nature Immunology this week, provide the ... "The science community has known that platelets do participate ...
Breaking Biology News(10 mins):New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 2New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 3New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 4No danger of cancer through gene therapy virus 2Immunity mechanism discovered 2
... disease-causing invader that creates a fuzzy gray coating on ... access to a different type of pathogen. , A ... Austria and North Carolina identified the gene that helps ... disease. The gene and its defense mechanisms are similar ...
... Genome Research , a team of scientists reports that 'mad ... history, nor have been cannibalistic rituals that are known to ... scientist at the Universitat Pompeu Fabra, and his colleagues used ... selection associated with cannibalism has not been a major selective ...
... illegal trade in the Roti Island snake-necked turtle, found only on ... the wild. Exotic pet enthusiasts in Europe, North America and ... without realizing that they are contributing to its demise. No ... , The report by TRAFFIC, the wildlife trade monitoring network ...
Cached Biology News:Gene thwarts some pathogens, gives access to others, could save crops 2Gene thwarts some pathogens, gives access to others, could save crops 3History of human cannibalism eats away at researchers 2Illegal trade is propelling rare turtle toward extinction, new report 2
In Western blotting antibodies recognize 94 K protein band, which corresponds to S-layer protein...
... The EZ-Tn5™ Plasmid-Based Deletion Machine is based ... transposition system developed by Goryshin and Reznikoff, ... of nested families of deletions and inversions ... in a transposon-containing plasmid vector. Although most ...
High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....
... kit is designed to knockout or alter genes ... than one week. Red/ET recombination allows the exchange ... specific, and faithful manner. An FRT-flanked kanamycin resistance ... can be used to replace a gene on ...
Biology Products: